Having trouble viewing this email? View in your browser.
ESCMID Logo

3 September 2019
WEEKLY NEWS

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,
ESCMID Executive Office.

 

2020 ESCMID Research grants: submit your scientific project now!

ESCMID research grants help young outstanding investigators pursue ground-breaking research in the fields of clinical microbiology and infectious diseases. Applications are accepted from the 1st of July to the 13th of September 2019.

For the Research Grant programme 2020, ESCMID only accepts projects dealing with
Bacterial Infections & Diseases (incl. diagnostics, pathogenesis, antibacterial susceptibility & resistance, antibacterial stewardship, vaccines). Click here to find out more!

 

› Read more

EUCIC Infection Prevention and Control Certificate – New program opening in 2020

Registrations are now being accepted for the next EUCIC Infection Prevention and Control Certificate programme, to commence in 2020.

You can find out more about the programme and register on the EUCIC website

› Read more

ECCMID 2019 donations - Thank you for your support!

On behalf of the ESCMID Executive Committee, we would like to thank all ECCMID 2019 speakers that decided to donate part of their reimbursement to support ESCMID scientific activities.

These generous donations will be used to support outstanding scientific research in the fields of CM and ID, to increase the number of ECCMID Travel Grants and to offer additional ESCMID Funded Observerships. Once again we express our sincere gratitude to the ECCMID invited speakers and chairs for contributing to the scientific success of our Congress.

 

The ESCMID awards nomination period is now open!

Don’t miss this month’s opportunity to nominate your outstanding colleagues for the following prestigious ESCMID awards, to be presented at ECCMID 2020 in Paris.

  • ESCMID Award for Excellence in Clinical Microbiology and Infectious Diseases
  • ESCMID Young Investigator Award for Research in Clinical Microbiology and Infectious Diseases
  • ESCMID TAE Outstanding Trainee Award in Clinical Microbiology and Infectious Diseases

The call for 2020 ESCMID awards will close on 08 October 2019 12:00 CET.

Click here to find out more information about the ESCMID awards and submit your nominations!

› Read more
 

WHO-ESCMID Observership Programme 2019 – Apply Now!

Applications are now open for the 2019 ESCMID funded observership programme at the WHO regional office in Cophenhagen, Denmark. Find out more about the programme and submit your application on the ESCMID observership website.

Applications close at 26 September 2019, 12:00 noon CET.

› Read more
 

First ESCMID course on developing clinical guidelines: building the ESCMID Guidelines Evidence Review group

ESCMID is strongly committed to increase efforts towards the transparent and rigorous production of guidance documents in the fields of infectious diseases, clinical microbiology and infection control. To this end, we are currently selecting ESCMID members for the Guidelines Evidence Review Group.

The ideal candidate is a motivated young professional willing to participate to a dedicated training course (14-16 October 2019, Verona, Italy) and to be available for systematic reviews in future ESCMID guidelines projects.

If you are interested in this opportunity, please follow the link to discover more.

› Read more
 

GARDP Webinar: Models for antimicrobial R&D: Advanced and complex in vivo models for infectious disease research

Don’t miss the next GARDP webinar, taking place on Tuesday September 10. For the September edition, Peter Warn (Senior Vice President, Anti-infective Discovery, Evotec) will review the experimental design and conduct of advanced or complex animal models for antimicrobial research.

Register for the Webinar at the GARDP Website

› Read more
 

CMI Highlight: Respiratory specimens and the diagnostic accuracy of aspergillus lateral flow assays (LFA-IMMYTM): real life data from a multicenter study

Lass-Flörl et. Al evaluate the new Aspergillus specific point-of-care test LFA-IMMYTM with respect to the ability to accurately detect Aspergillus in broncho-alveolar fluids and sputa and to clarify the potential of cross reactivity with other fungal pathogens, in order to meet the requirement for early diagnosis.Proper diagnosis of invasive aspergillosis is challenging, as conventional methods lack sensitivity and are complicated due to time-consuming incubation processes.

Respiratory specimens (n=398) from non-selected patients (n=390) underwent either fungal microscopy, culture or both prior to Aspergillus lateral flow assay (LFA-IMMYTM) testing.

For Aspergillus culture and microscopy positive samples, sensitivity (48/52) and specificity (44/48) was 92% (95%CI 8.0-9.7) and 91% (95%CI 7.9-9.7), respectively; cross-reactivity was documented with non-Aspergillus pathogens.

The authors conclude that LFA-IMMYTM is a reliable diagnostic tool for the detection of Aspergillus being present in respiratory samples

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.